SAGICO — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

SAGICO is a privately-held spinal implant company founded in 2019, headquartered in San Francisco with administrative offices in Tampa, Florida. The company's core technology is its 4D (Length, Width, Height, Lordosis) design philosophy for spinal restoration devices, which have been used in thousands of procedures internationally. Operating as part of a larger, diversified family conglomerate, SAGICO focuses on bringing next-generation spinal implants to market through a rapid, surgeon-informed development process. It is currently in the commercial stage for its implant systems outside the U.S., while navigating regulatory pathways for broader market access.

Spinal DisordersOrthopedics

Technology Platform

Proprietary 4D Sagittal Restoration Technology (Length + Width + Height + Lordosis) for designing spinal implants that restore natural spinal curvature. Utilizes a broad family of materials (metals, polymers, biomaterials) and a surgeon-informed, feedback-driven development process.

Opportunities

The large and growing global spinal implant market, particularly in the U.S., presents a major opportunity.

Successfully leveraging its 4D technology to demonstrate superior patient outcomes in sagittal alignment could allow SAGICO to capture market share.

Expansion through its existing international distributor network into new regions offers additional growth potential.

Risk Factors

High regulatory risk, especially for U.S.

FDA clearance, which is critical for significant growth.

The spinal device market is intensely competitive, dominated by large, well-capitalized companies with entrenched relationships.

Dependence on a parent conglomerate's strategic priorities and a global distributor network introduces execution and control risks.

Competitive Landscape

SAGICO competes in the highly consolidated spinal implant market against giants like Medtronic, Stryker, Johnson & Johnson (DePuy Synthes), and Zimmer Biomet. Its differentiation is based on its proprietary 4D lordosis-focused design philosophy, competing against other companies offering expandable cages and lordotic implants. Success requires proving clinical superiority and building strong surgeon adoption against competitors with vast sales forces and R&D resources.

More companies in Digital Health & Biotech SaaS →More companies in United States →